The treating doctor will have to carefully weigh expected benefits against potential risks in pregnant women in whom Acyclovir 200/400/800 Stada therapy proves necessary.
Acyclovir has been detected in breast milk following administration of acyclovir products. Breast-feeding is therefore discouraged while taking Acyclovir 200/400/800 Stada.